Atlas Trials

Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19)

Clinical trial NCT04448769 · COMPLETED

Trial details

NCT number
NCT04448769
Sponsor
Central Hospital, Nancy, France
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronavirus InfectionPrevalence
Start date
2020-06-26
Primary completion
2020-07-24
Enrollment
2006

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.